News and publishing service for psychedelic related companies
Contact us:
415.949.5050
twitter
facebook
linkedin
News and publishing service for psychedelic related companies
Home
About
Clients
NewsRoom
Solutions
Events
Contact
PNW Headlines
Silo Pharma Inc.’s (SILO) Ketamine Study Produces Positive Endpoint, Topical Formulation Reduces Nerve Pain
Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Cleared for Historic Study, Begins Enrolling Participants
DEA Sued Again for Denying Terminally Ill Patients Access to Psilocybin Therapy
Legislators in San Francisco File Initiative to Locally Decriminalize Psychedelics
Compass Pathways Appoints New CEO
Home
»
News Article
PsychedelicNewsWire Currently Accepts
Bitcoin
Bitcoin Cash
Dogecoin
Ethereum
Litecoin
USD Coin
Contact us:
415.949.5050
